Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

BUY
$463.67 - $597.16 $231,835 - $298,580
500 New
500 $248,000
Q4 2020

Feb 05, 2021

SELL
$510.68 - $643.45 $204,272 - $257,380
-400 Closed
0 $0
Q3 2020

Nov 06, 2020

SELL
$454.43 - $535.6 $45,443 - $53,560
-100 Reduced 20.0%
400 $206,000
Q2 2020

Aug 13, 2020

BUY
$334.87 - $493.06 $167,435 - $246,530
500 New
500 $226,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.46B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Gabelli & CO Investment Advisers, Inc. Portfolio

Follow Gabelli & CO Investment Advisers, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gabelli & CO Investment Advisers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Gabelli & CO Investment Advisers, Inc. with notifications on news.